Experts hail ‘remarkable’ trial results for treatment of a form of skin cancer that once had grim prognosis
More than half of people diagnosed with advanced melanoma now survive for at least 10 years when they receive a double hit of immunotherapy drugs, a trial has found.
The combined treatment has transformed survival rates for a form of skin cancer that once had a grim prognosis, with some patients now living long enough that they die from other causes.
More Stories
Sweden warns of heightened risk of Russian sabotage
New iMessage feature allows children to report nudity to Apple
Tens of thousands of UK dementia patients to be enrolled in clinical trials